Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 9/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.37 |
| ▸ | BUB1 | O43683 | 1/20 | 0.36 |
| ▸ | WNT1 | P04628 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2315657 | 0.88 | NPY5R (0.47) | GSK3BDYRK1ADEGS1NPY5R | |
| SCHEMBL2322316 | 0.84 | RIOK2 (0.41) | GSK3BDYRK1A | |
| SCHEMBL2359910 | 0.83 | MAP4K4 (0.40) | GSK3BDYRK1AMAP4K4DEGS1 | |
| SCHEMBL2320294 | 0.77 | WNT3A (0.49) | GSK3BDYRK1AMAPK14 | |
| SCHEMBL2318025 | 0.75 | TSHR (0.58) | DEGS1 | |
| SCHEMBL2317358 | 0.75 | NPY5R (0.49) | GSK3BDYRK1AMAPK14NPY5RWNT1 | |
| SCHEMBL12284201 | 0.72 | WNT3A (0.44) | GSK3BDYRK1AMAPK14WNT1 | |
| SCHEMBL2317315 | 0.72 | MEN1 (0.38) | DYRK1A | |
| SCHEMBL2317072 | 0.65 | MAPK8 (0.52) | GSK3BMAP4K4MAPK14DEGS1 | |
| SCHEMBL2316827 | 0.65 | WNT3A (0.58) | GSK3BDYRK1ADEGS1NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110230497-A1 | BIOLOGICALLY ACTIVE AMIDES | H. LUNDBECK A/S (DK) | 2011-09-22 | — | — | US | disclosed |
| EP-2352730-A2 | BIOLOGICALLY ACTIVE AMIDES | H. Lundbeck A/S (DK) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010053861-A2 | BIOLOGICALLY ACTIVE AMIDES | H. LUNDBECK A/S (DK) | 2010-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230497-A1 | BIOLOGICALLY ACTIVE AMIDES | NPY5R, NPY1R, NPY2R | GSK3B 2646/4885DYRK1A 1159/4885MAP4K4 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.